Hoechst Marion Roussel, a major player in the global pharmaceutical industry, is committed to building a world-class team of scientists dedicated to Drug Innovation & Approval. Our new state-of-the-art $70 million facility, has more than doubled the U.S. Research capabilities at our scenic campus in Bridgewater, New Jersey. These modern facilities with spacious labs and open interaction areas facilitate an exciting and creative team environment. All of our highly skilled scientists, participate on U.S. Drug Innovation teams, pursuing novel therapeutic targets for the treatment of Alzheimer's disease, asthma, cancer, schizophrenia, and stroke.
If you are driven to make a difference, please stop by our exhibit booth for additional information.
Positions Available:
We are seeking both experienced and newly degreed Ph.D.'s and postdoctoral scientists,
with experience in the following areas:
* Molecular Biology
* Molecular Pathology
* Microscopy & Imaging technologies
* Cell Biology
* Biochemistry
* Protein Biochemistry
* Pharmacology
* Physiology
* Organic Chemistry
* Medicinal Chemistry
Summary from Hoechst Marion Roussel home page:
Beyond Medicine to HealthTM
As one of the world's leading pharmaceutical companies, Hoechst Marion Roussel is committed to discovering and developing a wide range of innovative pharmaceuticals for our customers in the United States and around the globe. But we don't stop there. We go beyond medicine, providing customers with the tools and services needed to improve patient health.
For years, we've understood there's more to patient wellness than drug therapy. That's why we partner closely with health care providers, offering value-added programs that address such critical issues as health economics, information management, patient involvement and professional education.
Partners in Health Care
We continually develop new initiatives designed to give providers, payors and plans the information and services they need to meet the demands of today's dynamic marketplace. Our Managed Care Digest Series™ publications and The State of Health Care in America report are two such initiatives.
For patients, we create tailored education, compliance and culturally appropriate materials that help them understand that good health is more than just good medicine. Whether through powerful support programs like CardiSense® or information-packed Web sites like AllerDays®, we help patients take an active role in improving their health.
Focused on the Future
At Hoechst Marion Roussel, our success depends on how well we listen and learn from our customers. We're dedicated to serving health care delivery needs, providing everything from innovative drug therapies to disease management information to patient education.
At Hoechst Marion Roussel, we believe we can best contribute to the health of patients today -- and tomorrow -- by going beyond medicine to health™.
- Who We Are ...anticipating and responding to today's health care needs in the United States -- our history, our U.S. presence, and more.
- Our Products ...discovering and delivering high-quality drug therapies in the U.S. and around the world.
- Our Drug Innovation & Approval Strategy ...using our worldwide expertise to develop innovative new therapies that address unmet medical needs.
- Health Care Professional Support ...developing new initiatives that help health care providers, payors and plans to enhance their quality of care and improve cost-effectiveness.
- Patient Education Programs ...pioneering nationally recognized patient education, patient involvement and cultural marketing initiatives.
- Community Involvement and Philanthropy ...supporting educational, scientific and economic initiatives in communities where we have facilities, a major business presence or the opportunity to expand innovative local program models into national initiatives.
Hoechst Marion Roussel has career opportunities in the United States in the following functional areas: